Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation-Reference-Cited by-同舟云学术

Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation

Published:2011-12 Issue:11 Volume:82 Page:1619-1629
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Calviño Eva,Estañ María Cristina,Simón Gloria P.,Sancho Pilar,Boyano-Adánez María del Carmen,de Blas Elena,Bréard Jacqueline,Aller Patricio

Funder

Ministerio de Ciencia e Innovación, Spain

Plan Nacional de Investigación Científica

Desarrollo e Innovación Tecnológica

Dirección General de Investigación

Programa Consolider-Ingenio 2010

Consejo Superior de Investigaciones Científicas

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference37 articles.

1. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors;Di Cosimo;Drug Today,2003

2. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis;Sordet;Blood,2001

3. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells;Hulleman;Blood,2009

4. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437;Belzacq;Oncogene,2001

5. Mechanisms of action of arsenic trioxide;Miller;Cancer Res,2002

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Trastuzumab and Lonidamine‐Loaded Lipid Nanoparticles (LNP) on HER2+ Breast Cancer;ChemistrySelect;2024-06-07

2. Caspase-3 Activators as Anticancer Agents;Current Protein & Peptide Science;2023-12

3. Advances in the Study of Hexokinase 2 (HK2) Inhibitors;Anti-Cancer Agents in Medicinal Chemistry;2023-04

4. Developmental arsenic exposure: Behavioral dysfunctions and neurochemical perturbations;Handbook of Arsenic Toxicology;2023

5. Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components;Cancers;2022-03-12